B
BioNexus Gene Lab Corp. (BGLC)
NCM – Real Time Price. Currency in USD
2.35
-0.14 (-5.69%)
At close: Mar 27, 2026, 4:00 PM EDT
2.36
+0.01 (0.49%)
After-hours: Mar 27, 2026, 7:37 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.35
-0.14 (-5.69%)
At close: Mar 27, 2026, 4:00 PM EDT
2.36
+0.01 (0.49%)
After-hours: Mar 27, 2026, 7:37 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.30 | 2.71 | 10 | |
| Quick ratio | 6.81 | 1.86 | 10 | |
| Debt to Equity | 0.03 | 0.44 | 9.0 | |
| Debt to Assets | 0.02 | 0.37 | 9.0 | |
| Interest coverage | -125.00 | 72.59 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 13M | 11M | 10M | 10M | 9M |
| Gross Profit | 2M | 1M | 1M | 1M | 1M |
| Operating Income | 989K | -470K | -3M | -2M | -2M |
| Net Income | 752K | -356K | -3M | -2M | -2M |
| EBITDA | 1M | -365K | -3M | -2M | -1M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 12.55 | -15.05 | N/A | -65 | 2.8 |
| Y/Y | -3.28 | 47.3 | N/A | 23.64 | 5.5 |
| 3y average | -10.47 | -248.89 | N/A | 539.21 | 3.3 |
| 5y average | 1771.58 | -46.81 | N/A | 339.55 | 5.5 |
| Weighted average score | 4.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $2.9M significantly exceed its total debt $183.7K, ensuring strong financial flexibility
Total current assets $5.6M exceed Total current liabilities $678.0K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.4), showcasing prudent financial management
Interest coverage ratio (-125.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.2M limits the company's ability to reinvest or pay down debt